Skip to main content
Fig. 1 | Trials

Fig. 1

From: Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenza: study protocol for a randomized parallel placebo-controlled double-blind multicenter trial

Fig. 1

Study flowchart. Participants with severe influenza will be recruited, and they will be assigned randomly into two different groups. All participants will accept the 1-day screening, 7-day intervention, and 21-day observation. The data were collected to determine the efficacy and safety of QZQG Formula as an adjuvant therapy

Back to article page

Trials

ISSN: 1745-6215